Index of reports
> Cases with General Physical Health Deterioration (4)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Istodax (Romidepsin) where reactions include general physical health deterioration. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Istodax side effects in female
Reported by a physician from France on 2012-07-18
Patient: female, weighing 40.0 kg (88.0 pounds)
Reactions: Pneumonia, General Physical Health Deterioration, Febrile Neutropenia, Neutrophil Count Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Adriamycin PFS
Indication: non-Hodgkin's Lymphoma
Start date: 2011-10-27
End date: 2012-04-13
Cyclophosphamide
Indication: non-Hodgkin's Lymphoma
Start date: 2011-10-27
End date: 2012-04-13
Istodax
Indication: non-Hodgkin's Lymphoma
Start date: 2011-10-27
End date: 2012-04-12
Prednisone
Indication: non-Hodgkin's Lymphoma
Start date: 2011-10-27
End date: 2012-04-13
Vincristine
Indication: non-Hodgkin's Lymphoma
Start date: 2011-10-27
End date: 2012-04-13
Possible Istodax side effects in female
Reported by a physician from France on 2012-06-27
Patient: female, weighing 40.0 kg (88.0 pounds)
Reactions: General Physical Health Deterioration, Febrile Neutropenia, Pyrexia, Neutrophil Count Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Adriamycin PFS
Indication: non-Hodgkin's Lymphoma
Start date: 2011-10-27
End date: 2012-04-13
Cyclophosphamide
Indication: non-Hodgkin's Lymphoma
Start date: 2011-10-27
End date: 2012-04-13
Istodax
Dosage: 14 milligram
Indication: non-Hodgkin's Lymphoma
Start date: 2011-10-27
End date: 2012-04-12
Prednisone TAB
Indication: non-Hodgkin's Lymphoma
Start date: 2011-10-27
End date: 2012-04-13
Vincristine Sulfate
Indication: non-Hodgkin's Lymphoma
Start date: 2011-10-27
End date: 2012-04-13
Possible Istodax side effects in female
Reported by a physician from France on 2012-05-29
Patient: female, weighing 40.0 kg (88.0 pounds)
Reactions: Febrile Neutropenia, General Physical Health Deterioration, Pyrexia, Neutrophil Count Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Adriamycin PFS
Indication: non-Hodgkin's Lymphoma
Start date: 2011-10-27
End date: 2012-04-13
Cyclophosphamide
Indication: non-Hodgkin's Lymphoma
Start date: 2011-10-27
End date: 2012-04-13
Istodax
Dosage: 14 milligram
Indication: non-Hodgkin's Lymphoma
Start date: 2011-10-27
End date: 2012-04-12
Prednisone TAB
Indication: non-Hodgkin's Lymphoma
Start date: 2011-10-27
End date: 2012-04-13
Vincristine
Indication: non-Hodgkin's Lymphoma
Start date: 2011-10-27
End date: 2012-04-13
Possible Istodax side effects in female
Reported by a physician from Italy on 2012-05-01
Patient: female
Reactions: Weight Decreased, Night Sweats, Product Contamination Microbial, Blood Lactate Dehydrogenase Increased, Drug Intolerance, Anaemia, Congestive Cardiomyopathy, General Physical Health Deterioration, Pyrexia, Death, Peripheral T-Cell Lymphoma Unspecified, Asthenia, Decreased Appetite
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Istodax
Indication: Peripheral T-Cell Lymphoma Unspecified
Start date: 2011-11-30
End date: 2011-12-14
Istodax
Start date: 2012-01-09
Other drugs received by patient: Corticosteroids
|